Technology News and Research

RSS

QIAGEN acquires rights to 70 molecular food safety tests developed by Institute for Product Quality

QIAGEN today announced that it has entered into an agreement with the Institute for Product Quality (ifp), pursuant to which QIAGEN has acquired all rights to 70 molecular food safety tests developed by the Berlin-based specialized laboratory center for food analysis.

From QIAGEN Manchester Limited 26 May 2010

Heptares Therapeutics, O2h extend multi-FTE -synthetic chemistry services collaboration

Executives from Heptares Therapeutics (Welwyn Garden City, UK) and O2h (Cambridge, UK) announced today an extension of the agreement under which O2h provides multi-FTE -synthetic chemistry services to support discovery programmes at Heptares.

26 May 2010

Benefit Advocates launches its redesigned website

Benefit Advocates Inc. recently launched its redesigned website at www.benefitadvocates.net. The new design offers visitors ease of use and comprehensive information on Benefit Advocates' company profile, employer and broker services, and healthcare industry perspectives.

26 May 2010

St. Jude Medical initiates enrollment in FAME II trial for coronary artery disease

St. Jude Medical, Inc., a global medical device company, announced today at EuroPCR that the first patient was enrolled in the FAME II (Fractional Flow Reserve (FFR)-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment vs. Optimal Medical Treatment Alone in Patients with Stable Coronary Artery Disease) trial.

25 May 2010

Bayer selects Vision Chain as Enterprise Demand Signal Repository and Predictive Analytics platform

Vision Chain, Inc., the leading global provider of demand signal repository and predictive analytic solutions, announced today that Bayer Healthcare LLC, the global leader in trusted brands for healthcare and nutrition, has licensed its technology platform to analyze store-specific sales, assortments, prices, promotions and other factors to optimize go-to-market efforts with multiple retailers.

25 May 2010

Halfpenny Technologies releases new critical value alerting, reporting feature for ITF-GoDoc solution

Halfpenny Technologies, Inc., a leading health information exchange (HIE) solutions provider specializing in laboratory, pathology and physician electronic medical record (EMR) system interoperability, has introduced a new critical value alerting and reporting feature for its ITF-GoDoc solution. ITF-GoDoc enables physicians to securely access laboratory, pathology and radiology result reports from their iPhone, Droid or Blackberry Storm-powered smartphones.

25 May 2010

Applied Spine Technologies awarded U.S. patents for 'Dynamic Spine Stabilizer' and 'Spring Junction'

Applied Spine Technologies, Inc., a medical device company focused on motion preservation of the lumbar spine, was awarded two new patents by the U.S. Patent and Trademark Office on May 11, 2010.

25 May 2010

YesDTC acquires DRTV marketing rights to patented MediPendant medical alarm device

YesDTC Holdings, Inc., a direct-to-consumer global distributor and marketer of consumer goods and products, announced today, the Company has acquired the rights to market the patented MediPendant™ medical alarm device from Medical Alarm Concepts Holding, Inc. via direct response television (DRTV).

25 May 2010

Exactech acquires Brighton Partners

Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has acquired Brighton Partners, Inc., the sole source supplier of the direct compression molded polyethylene bearings used exclusively in Exactech's flagship product, the Optetrak® knee replacement system.

25 May 2010

T2 Biosystems raises $15 million to accelerate development of next generation diagnostic platform

T2 Biosystems, Inc., a company developing the first decentralized clinical diagnostic solution that eliminates extensive sample preparation and enables rapid molecular and immunodiagnostic testing on a single instrument, today announced that it has raised approximately $15 million in a Series C financing. Proceeds from the financing will be used to accelerate the development and commercialization of T2 Biosystems' next generation diagnostic platform for use in the decentralized setting.

25 May 2010

CoDa Therapeutics reports positive results from Phase 2 study of NEXAGON for chronic venous leg ulcers

CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.

25 May 2010

VentureMD closes on fund to incubate promising medical device technologies into successful companies

VentureMD, a seed stage medical device business accelerator, has closed on a fund to incubate promising medical device technologies into successful companies.

25 May 2010

Significant progress on international development strategy for stem cell-derived human corneal tissue

International Stem Cell Corporation, www.intlstemcell.com, today announced significant progress on its international development strategy for stem cell-derived human corneal tissue. Such tissue can potentially be used to replace cadaver-derived corneas in treatment of severe corneal vision impairment and to eliminate the need to use live animals in safety testing of drugs, chemicals and consumer products.

25 May 2010

Sonomax Technologies signs collaboration agreement with DEC

Sonomax Technologies Inc. is pleased to announce that is has signed a collaboration agreement with the Dynamic Ear Company. DEC is a leading manufacturer and developer of innovative in-ear products that permit users to control the volume of external sound that reaches their ears, which by doing so, contribute to hearing safety and a comfortable sound experience.

25 May 2010

Yissum introduces Dralgo platform to accelerate discovery of promising drug candidates

Drug discovery and development is a highly risky process, with only one in 10,000 initial candidate compounds reaching the market. When taking into account the aborted candidates, the cost of developing one successful drug may even reach $1 billion, and the development process may take as long as 15-20 years.

25 May 2010

ImmunoGen to present clinical data on IMGN388 solid tumor compound at 2010 ASCO

ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that there will be several clinical data presentations for compounds utilizing the Company's Targeted Antibody Payload (TAP) technology at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO) being held in Chicago on June 4-8, 2010.

25 May 2010

Researchers develop new device that can change current landscape of chronic wound management

Complex wounds affect more patients in the United States than heart attack and stroke combined, and five to seven million Americans with complex wounds account for over $20 billion in healthcare expenditures. About 150,000 amputations a year result from complex wounds, while about 80,000 are attributed to diabetes and peripheral arterial disease.

25 May 2010

Hospitalar Welch Allyn to feature electronic connected solutions for frontline caregivers in Latin America

Hospitalar—Welch Allyn, a leading global manufacturer of frontline medical products and solutions, is reconfirming its commitment to caregivers in Latin America with innovative solutions to healthcare issues that are unique to the region. In March 2009 the company acquired MD International (MDI), now Welch Allyn Latin America, and has since gained significant market share in South and Central America, Mexico and the Caribbean thanks to strong relationships with large distribution and manufacturer partners.

25 May 2010

Agilent Technologies, Stemina Biomarker Discovery to accelerate metobolomic research

Agilent Technologies Inc. and Stemina Biomarker Discovery, Inc. today announced efforts to accelerate Stemina's metobolomic research. Stemina uses metabolomic analysis of stem cells for the discovery of biomarkers for use in drug screening and drug development.

25 May 2010

EHSI reports favorable completion of due diligence with Stand-By Systems

Emerging Healthcare Solutions, Inc. disclosed today that the Company has just favorably completed the financial review phase of due diligence with Stand-By Systems. EHSI recently executed an option with Stand-By Systems; owner of the new FDA approved SBS 1615 catalytic oxygen generator, as well as the associated LIFEDGE® and MAYDAY® emergency systems. EHSI is currently performing due diligence under this option.

25 May 2010

Technology News and Research

QIAGEN acquires rights to 70 molecular food safety tests developed by Institute for Product Quality

Heptares Therapeutics, O2h extend multi-FTE -synthetic chemistry services collaboration

Benefit Advocates launches its redesigned website

St. Jude Medical initiates enrollment in FAME II trial for coronary artery disease

Bayer selects Vision Chain as Enterprise Demand Signal Repository and Predictive Analytics platform

Halfpenny Technologies releases new critical value alerting, reporting feature for ITF-GoDoc solution

Applied Spine Technologies awarded U.S. patents for 'Dynamic Spine Stabilizer' and 'Spring Junction'

YesDTC acquires DRTV marketing rights to patented MediPendant medical alarm device

Exactech acquires Brighton Partners

T2 Biosystems raises $15 million to accelerate development of next generation diagnostic platform

CoDa Therapeutics reports positive results from Phase 2 study of NEXAGON for chronic venous leg ulcers

VentureMD closes on fund to incubate promising medical device technologies into successful companies

Significant progress on international development strategy for stem cell-derived human corneal tissue

Sonomax Technologies signs collaboration agreement with DEC

Yissum introduces Dralgo platform to accelerate discovery of promising drug candidates

ImmunoGen to present clinical data on IMGN388 solid tumor compound at 2010 ASCO

Researchers develop new device that can change current landscape of chronic wound management

Hospitalar Welch Allyn to feature electronic connected solutions for frontline caregivers in Latin America

Agilent Technologies, Stemina Biomarker Discovery to accelerate metobolomic research

EHSI reports favorable completion of due diligence with Stand-By Systems

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News